Efficacy and safety of subcutaneous immunotherapy combined with omalizumab in children with dust mite-induced asthma

References

• Thomas WR. House dust allergy and immunotherapy. Hum Vaccin Immunother. 2012;8(10):1469–1478.
   PubMed Web of Science ®Google Scholar
• Thomas WR, Hales BJ, Smith WA. House dust mite allergens in asthma and allergy. Trends Mol Med. 2010;16(7):321–328.
   PubMed Web of Science ®Google Scholar
• Twaroch TE, Curin M, Valenta R, Swoboda I. Mold allergens in respiratory allergy: from structure to therapy. Allergy Asthma Immunol Res. 2015;7(3):205–220. doi:10.4168/aair.2015.7.3.205.
   PubMed Web of Science ®Google Scholar
• Jutel M, Agache I, Bonini S, Burks AW, Calderon M, Canonica W, Cox L, Demoly P, Frew AJ, O’Hehir R, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2015;136(3):556–568. doi:10.1016/j.jaci.2015.04.047.
   PubMed Web of Science ®Google Scholar
• Halken S, Høst A, Niklassen U, Hansen LG, Nielsen F, Pedersen S, Osterballe O, Veggerby C, Poulsen LK. Effect of mattress and pillow encasings on children with asthma and house dust mite allergy. J Allergy Clin Immunol. 2003;111(1):169–176. doi:10.1067/mai.2003.5.
   PubMed Web of Science ®Google Scholar
• [WHO position paper. “Allergen immunotherapy: therapeutic vaccines for allergic diseases”]. Arerugi. 1998;47(7):698–704.
   PubMedGoogle Scholar
• Chinese Journal of Pediatrics Editorial Board, Respiratory Group, Chinese Society of Pediatrics, Chinese Medical Association, Pediatric Respiratory Committee, Chinese Medical Doctor Association. Recommendations for standardized diagnosis and treatment of bronchial asthma in children (2020 edition). Chin J Pediatrics. 2020;58(9):708–717.
   Google Scholar
• Children’s Otorhinolaryngology Committee, Pediatricians Branch, Chinese Medical Doctor Association. Clinical practice guidelines for the diagnosis and treatment of allergic rhinitis in children. Chin J Pediatr. 2019;34(3):169–175.
   Google Scholar
• Li X, et al. Expert consensus on mite specific immunotherapy for children with airway allergic diseases. Chinese Journal of Practical Pediatrics. 2018;33(16):1215–1223.
   Google Scholar
• National Clinical Medical Research Center for Respiratory Diseases, et al. Expert consensus on the clinical use of omalizumab in children with allergic asthma. Chinese Journal of Practical Pediatrics. 2021;36(12):881–890.
   Google Scholar
• Professor Ye Shitai spoke at the Lifetime Achievement Award of the Chinese Medical Association in Allergy. Chin J Clin Immunol Allergy. 2013;7(2):206.
   Google Scholar
• Olsen OT, Larsen KR, Jacobsan L, Svendsen UG. A 1-year, placebo-controlled, double-blind house-dust-mite immunotherapy study in asthmatic adults. Allergy. 1997;52(8):853–859. doi:10.1111/j.1398-9995.1997.tb02157.x.
   PubMed Web of Science ®Google Scholar
• Dahl R, Stender A, Rak S. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy. 2006;61(2):185–190. doi:10.1111/j.1398-9995.2005.00949.x.
   PubMed Web of Science ®Google Scholar
• Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol. 2005;116(3):608–613. doi:10.1016/j.jaci.2005.06.004.
   PubMed Web of Science ®Google Scholar
• Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J Allergy Clin Immunol. 2010;125(3):569.e1–574.e7. doi:10.1016/j.jaci.2009.10.060.
   Web of Science ®Google Scholar
• Rodríguez Del Río P, Vidal C, Just J, Tabar AI, Sanchez-Machin I, Eberle P, Borja J, Bubel P, Pfaar O, Demoly P, et al. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a paediatric assessment. Pediatr Allergy Immunol. 2017;28(1):60–70. doi:10.1111/pai.12660.
   PubMed Web of Science ®Google Scholar
• Cox L, Compalati E, Kundig T, Larche M. New directions in immunotherapy. Curr Allergy Asthma Rep. 2013;13(2):178–195. doi:10.1007/s11882-012-0335-7.
   PubMed Web of Science ®Google Scholar
• Kopp MV, Hamelmann E, Bendiks M, Zielen S, Kamin W, Bergmann K-C, Klein C, Wahn U, DUAL study group Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy. Pediatr Allergy Immunol. 2013;24(5):427–433. doi:10.1111/pai.12098.
   PubMed Web of Science ®Google Scholar
• Kuperstock JE, Brook CD, Ryan MW, Platt MP. Correlation between the number of allergen sensitizations and immunoglobulin E: monosensitization vs polysensitization. Int Forum Allergy Rhinol. 2017;7(4):385–388. doi:10.1002/alr.21890.
   PubMed Web of Science ®Google Scholar
• Dantzer JA, Wood RA. The use of omalizumab in allergen immunotherapy. Clin Exp Allergy. 2018;48(3):232–240. doi:10.1111/cea.13084.
   PubMed Web of Science ®Google Scholar
• Stelmach I, Majak P, Jerzyńska J, Bojo M, Cichalewski Ł, Smejda K. Children with severe asthma can start allergen immunotherapy after controlling asthma with omalizumab: a case series from Poland. Arch Med Sci. 2015;11(4):901–904. doi:10.5114/aoms.2015.48546.
   PubMed Web of Science ®Google Scholar
• Zielen S, Kardos P, Madonini E. Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: a randomized controlled trial. J Allergy Clin Immunol. 2010;126(5):942–949. doi:10.1016/j.jaci.2010.06.002.
   PubMed Web of Science ®Google Scholar
• Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RCM, Coker-Schwimmer EJL, Rosen DL, Sista P, Lohr KN, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–795. doi:10.7326/0003-4819-157-11-201212040-00538.
   PubMed Web of Science ®Google Scholar
• Zuberbier T, Bachert C, Bousquet PJ, Passalacqua G, Walter Canonica G, Merk H, Worm M, Wahn U, Bousquet J. GA(2) LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy. 2010;65(12):1525–1530. doi:10.1111/j.1398-9995.2010.02474.x.
   PubMed Web of Science ®Google Scholar
• Jing L. Expert Consensus on clinical practice of specific immunotherapy in China. Chin J Tuberc Respir. 2012;3(35):163–166. doi:10.3760/cma.j.issn.1001-0939.2012.03.002.
   Google Scholar
• Virchow JC, Backer V, Kuna P, Prieto L, Nolte H, Villesen HH, Ljørring C, Riis B, de Blay F. Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial. JAMA. 2016;315(16):1715–1725. doi:10.1001/jama.2016.3964.
   PubMed Web of Science ®Google Scholar
• Asamoah F, Kakourou A, Dhami S, Lau S, Agache I, Muraro A, Roberts G, Akdis C, Bonini M, Cavkaytar O, et al. Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews. Clin Transl Allergy. 2017;7(1):25. doi:10.1186/s13601-017-0160-0.
   PubMed Web of Science ®Google Scholar
• Dhami S, Kakourou A, Asamoah F, Agache I, Lau S, Jutel M, Muraro A, Roberts G, Akdis CA, Bonini M, et al. Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis. Allergy. 2017;72(12):1825–1848. doi:10.1111/all.13208.
   PubMed Web of Science ®Google Scholar
• Papadopoulos NG, Arakawa H, Carlsen K-H, Custovic A, Gern J, Lemanske R, Le Souef P, Mäkelä M, Roberts G, Wong G, et al. International consensus on (ICON) pediatric asthma. Allergy. 2012;67(8):976–997. doi:10.1111/j.1398-9995.2012.02865.x.
   PubMed Web of Science ®Google Scholar
• Soyyigit S, Guloglu D, Ikinciogullari A, Secil D, Oztuna D, Mungan D, Misirligil Z, Sin BA. Immunologic alterations and efficacy of subcutaneous immunotherapy with Dermatophagoides pteronyssinus in monosensitized and polysensitized patients. Ann Allergy Asthma Immunol. 2016;116(3):244–251.e2. doi:10.1016/j.anai.2016.01.002.
   PubMed Web of Science ®Google Scholar
• Guan K. Evaluation of the efficacy and safety of immunotherapy for Humulus pollens. Chin J Clin Immunol Allergy. 2012;6(4):279–284. doi:10.3969/j.issn.1673-8705.2012.04.007.
   Google Scholar
• Ye S. Dynamic observation of serum IgE in patients with allergic rhinitis during specific desensitization. Chin J Otolaryngol. 1982;17:147.
   Google Scholar
• Shamji MH, Kappen JH, Akdis M, Jensen-Jarolim E, Knol EF, Kleine-Tebbe J, Bohle B, Chaker AM, Till SJ, Valenta R, et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy. 2017;72(8):1156–1173. doi:10.1111/all.13138.
   PubMed Web of Science ®Google Scholar
• Klunker S, Saggar LR, Seyfert-Margolis V, Asare AL, Casale TB, Durham SR, Francis JN, Immune Tolerance Network Group. Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: inhibition of IgE-facilitated allergen binding. J Allergy Clin Immunol. 2007;120(3):688–695. doi:10.1016/j.jaci.2007.05.034.
   PubMed Web of Science ®Google Scholar
• Sun Y, Liu L, Xing H. Safety of house dust mite allergen cluster immunotherapy versus conventional immunotherapy at initial stage in children with asthma. Chin J Clin Immunol Allergy. 2018;12(1):14–18.
   Google Scholar
• Caminiti L, Galletta F, Foti Randazzese S, Barraco P, Passanisi S, Gambadauro A, Crisafulli G, Valenzise M, Manti S. Early assessment of efficacy and safety of biologics in pediatric allergic diseases: preliminary results from a prospective real-world study. Children (Basel). 2024;11(2):170. doi:10.3390/children11020170.
   PubMed Web of Science ®Google Scholar
• Galletta F, Caminiti L, Lugarà C, Foti Randazzese S, Barraco P, D’Amico F, Irrera P, Crisafulli G, Manti S. Long-term safety of omalizumab in children with asthma and/or chronic spontaneous urticaria: a 4-year prospective study in real life. J Pers Med. 2023;13(7):1068. doi:10.3390/jpm13071068.
   PubMed Web of Science ®Google Scholar